Antimicrobial prescribing in people with cystic fibrosis: exploring inhaled antibiotic use for Pseudomonas aeruginosa infections across the ECFS-CTN

Callum Sloan; Laura Sherrard; Gisli Einarsson; Lieven J. Dupont; Nick  Simmonds; Silke van Koningsbruggen-Rietschel; Damian Downey

doi:10.1016/S1569-1993(22)00481-7

Antimicrobial prescribing in people with cystic fibrosis: exploring inhaled antibiotic use for Pseudomonas aeruginosa infections across the ECFS-CTN

Callum Sloan
, Laura Sherrard
, Gisli Einarsson
, Lieven J. Dupont
, Nick Simmonds
, Silke van Koningsbruggen-Rietschel
, Damian Downey

Research output: Contribution to journal › Meeting abstract › peer-review

Original language	English
Article number	P150
Pages (from-to)	S107
Number of pages	1
Journal	Journal of Cystic Fibrosis
Volume	21
Issue number	Supplement 1
DOIs	https://doi.org/10.1016/S1569-1993(22)00481-7
Publication status	Published - 01 Jun 2022
Event	45th European Cystic Fibrosis Conference 2022 - Ahoy Centre, Rotterdam, Netherlands Duration: 08 Jun 2022 → 11 Jun 2022 https://www.ecfs.eu/rotterdam2022

Access to Document

10.1016/S1569-1993(22)00481-7Licence: Unspecified

Levofloxacin: reducing the risk of Pseudomonas aeruginosa resistance
Sloan, C. M. (Author), Downey, D. (Supervisor) & Sherrard, L. (Supervisor), Dec 2024
Student thesis: Doctoral Thesis › Doctor of Philosophy

Cite this

Sloan, C., Sherrard, L., Einarsson, G., Dupont, L. J., Simmonds, N., van Koningsbruggen-Rietschel, S., & Downey, D. (2022). Antimicrobial prescribing in people with cystic fibrosis: exploring inhaled antibiotic use for Pseudomonas aeruginosa infections across the ECFS-CTN. Journal of Cystic Fibrosis, 21(Supplement 1), S107. Article P150. https://doi.org/10.1016/S1569-1993(22)00481-7

@article{2d2844d8f6d14d499c474fb4e76dc069,

title = "Antimicrobial prescribing in people with cystic fibrosis: exploring inhaled antibiotic use for Pseudomonas aeruginosa infections across the ECFS-CTN",

author = "Callum Sloan and Laura Sherrard and Gisli Einarsson and Dupont, \{Lieven J.\} and Nick Simmonds and \{van Koningsbruggen-Rietschel\}, Silke and Damian Downey",

year = "2022",

month = jun,

day = "1",

doi = "10.1016/S1569-1993(22)00481-7",

language = "English",

volume = "21",

pages = "S107",

journal = "Journal of Cystic Fibrosis",

issn = "1569-1993",

publisher = "Elsevier B.V.",

number = "Supplement 1",

note = "45th European Cystic Fibrosis Conference 2022, ECFS 2022 ; Conference date: 08-06-2022 Through 11-06-2022",

url = "https://www.ecfs.eu/rotterdam2022",

}

Sloan, C, Sherrard, L , Einarsson, G, Dupont, LJ, Simmonds, N, van Koningsbruggen-Rietschel, S & Downey, D 2022, 'Antimicrobial prescribing in people with cystic fibrosis: exploring inhaled antibiotic use for Pseudomonas aeruginosa infections across the ECFS-CTN', Journal of Cystic Fibrosis, vol. 21, no. Supplement 1, P150, pp. S107. https://doi.org/10.1016/S1569-1993(22)00481-7

Antimicrobial prescribing in people with cystic fibrosis: exploring inhaled antibiotic use for Pseudomonas aeruginosa infections across the ECFS-CTN. / Sloan, Callum; Sherrard, Laura ; Einarsson, Gisli et al.
In: Journal of Cystic Fibrosis, Vol. 21, No. Supplement 1, P150, 01.06.2022, p. S107.

Research output: Contribution to journal › Meeting abstract › peer-review

TY - JOUR

T1 - Antimicrobial prescribing in people with cystic fibrosis: exploring inhaled antibiotic use for Pseudomonas aeruginosa infections across the ECFS-CTN

AU - Sloan, Callum

AU - Sherrard, Laura

AU - Einarsson, Gisli

AU - Dupont, Lieven J.

AU - Simmonds, Nick

AU - van Koningsbruggen-Rietschel, Silke

AU - Downey, Damian

PY - 2022/6/1

Y1 - 2022/6/1

U2 - 10.1016/S1569-1993(22)00481-7

DO - 10.1016/S1569-1993(22)00481-7

M3 - Meeting abstract

SN - 1569-1993

VL - 21

SP - S107

JO - Journal of Cystic Fibrosis

JF - Journal of Cystic Fibrosis

IS - Supplement 1

M1 - P150

T2 - 45th European Cystic Fibrosis Conference 2022

Y2 - 8 June 2022 through 11 June 2022

ER -

Antimicrobial prescribing in people with cystic fibrosis: exploring inhaled antibiotic use for Pseudomonas aeruginosa infections across the ECFS-CTN

Access to Document

Student theses

Levofloxacin: reducing the risk of Pseudomonas aeruginosa resistance

Cite this